JUST IN: Nasir El-rufai loses mum

Nigeria, March 27 -- Former Kaduna State Governor Nasir El-Rufai has lost his mum, Umma El-Rufai. The woman reportedly died on Friday according to a post by Bello El-Rufai, a grandson of the deceased... Read More

Can Sagility Become a Leading AI-Driven Healthcare Outsourcing Play? Here's what Nomura says

India, March 27 -- The shares of a Small-Cap company, specialising in technology-enabled business process management (BPM) solutions exclusively for the U.S. healthcare industry, supporting both payer... Read More

Drones and mines: taking Kharg Island would pose risks for US troops

Dhaka, March 27 -- President Donald Trump has been weighing whether to use ground forces to seize Iran's strategic oil hub of Kharg Island, an operation analysts say could be achieved quickly, but lea... Read More

Propaganda Machine: Inside Russia's drive to shift Chad from Western influence

France, March 27 -- The documents were analysed as part of the investigative series Propaganda Machine, led by the pan-African outlet The Continent and the investigative network Forbidden Stories, wit... Read More

Six-lane road project worth Rs 160 crore to boost connectivity in Odisha's Sundargarh

Bhubaneswar, March 27 -- A road infrastructure project worth around Rs 160 crore is set to be taken up in Odisha's Sundargarh district, aimed at improving connectivity and addressing traffic congestio... Read More

Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airwa... Read More

Singapore Clinical Trial: CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safe... Read More

Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of L... Read More

Singapore Clinical Trial: CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib Plus Pembrolizumab Versus Pembrolizumab And Pemetrexed And Carboplatin or Cisplatin in Patients with Previously Untreated, KRAS G12C-Mutated, Advanced Or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasi... Read More

Singapore Clinical Trial: A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Du... Read More

• ««
• «
• 1099
• 1100
• 1101
• 1102
• 1103
• 1104
• 1105
• 1106
• 1107
• 1108
• »
• »»